FDA Inspection 1102408 — Island Reproductive Services
The FDA completed an inspection of Island Reproductive Services on Sep 12, 2019 in Staten Island, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Staten Island, NY (United States)